Spotlight Innovation Inc (AEXP) financial statements (2020 and earlier)

Company profile

Business Address 11147 AURORA AVENUE
URBANDALE, IA 50322
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0000000
Cash and cash equivalents0000000
Receivables0      
Inventory, net of allowances, customer advances and progress billings0000   
Inventory0000   
Prepaid expense0000000
Other current assets0      
Other undisclosed current assets    111
Total current assets:0000112
Noncurrent Assets
Property, plant and equipment0000000
Other undisclosed noncurrent assets7777777
Total noncurrent assets:7777777
TOTAL ASSETS:7777889
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:0011111
Accounts payable1110100
Accrued liabilities1111111
Settlement liabilities      0
Other undisclosed accounts payable and accrued liabilities(1)(1)     
Debt2111110
Deferred compensation liability0      
Due to related parties  00000
Other undisclosed current liabilities1100155
Total current liabilities:3333476
Noncurrent Liabilities
Long-term debt and lease obligation11110  
Long-term debt, excluding current maturities11110  
Other undisclosed noncurrent liabilities4332211
Total noncurrent liabilities:5544211
Other undisclosed liabilities    0  
Total liabilities:8776587
Stockholders' equity
Stockholders' equity attributable to parent, including:(3)(2)(2)(1)1(2)(1)
Common stock0000000
Additional paid in capital40404040403534
Retained earnings (accumulated deficit)(43)4242(41)(39)(37)(35)
Other undisclosed stockholders' equity attributable to parent0(85)(83)    
Stockholders' equity attributable to noncontrolling interest2222233
Total stockholders' equity:(1)(0)11311
TOTAL LIABILITIES AND EQUITY:7777889

Income statement (P&L) ($ in millions)

6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
Revenues0000  0
Financial services revenue(0)000(0)  
Other income  0 0 0
Cost of revenue
(Cost of Goods and Services Sold)
(0)(0)(0)(0)(0)(0) 
Gross profit:00(0)(0)(0)(0)0
Operating expenses(1)(1)(1)(1)(1)(2)(3)
Other undisclosed operating loss      (0)
Operating loss:(1)(1)(1)(1)(1)(2)(3)
Nonoperating expense(0)(0)(0)(1)(0)(0)(10)
Foreign currency transaction gain (loss), before tax0(0)(0)(0)(0)(0)(0)
Interest and debt expense(0)(0)(0)(0)(0)(1)(3)
Loss from continuing operations before income taxes:(1)(1)(1)(2)(2)(3)(15)
Other undisclosed income from continuing operations11122315
Income from continuing operations:0000000
Other undisclosed income before gain (loss) on sale of properties      0
Income before gain (loss) on sale of properties:0000000
Other undisclosed net loss(1)(1)(1)(2)(2)(2)(12)
Net loss:(1)(1)(1)(2)(2)(2)(12)
Other undisclosed net loss attributable to parent(0)(0)(0)(0)(0)(0)(0)
Net loss available to common stockholders, diluted:(1)(1)(1)(2)(2)(2)(12)

Comprehensive Income ($ in millions)

6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
Net loss:(1)(1)(1)(2)(2)(2)(12)
Comprehensive loss, net of tax, attributable to parent:(1)(1)(1)(2)(2)(2)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: